LONGEVIA GENOMICS
DEAD

Serial Number

87301043

Owner

LonGevia Genomics Srl

Attorney

Mark A. Jansen

Filing Date

Jan 13, 2017

Add to watchlist:

No watchlists yet
View on USPTO

LONGEVIA GENOMICS Trademark

Serial Number: 87301043 • Registration: 5711986

LONGEVIA GENOMICS is a trademark filed by LonGevia Genomics Srl on January 13, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

LonGevia Genomics Srl (2 trademarks)

c/o Studio Marongiu
Cagliari , IT

Entity Type: 11

Trademark Details

Filing Date

January 13, 2017

Registration Date

April 2, 2019

Published for Opposition

January 15, 2019

Cancellation Date

October 17, 2025

Goods & Services

Medical services; genetic counseling; health screening services for diseases, disorders and conditions in the fields of oncology and immunology; providing health information; performing diagnosis of diseases; RNA or DNA services analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; medical and health care services relating to DNA, genetics and genetic testing; DNA screening for medical purposes

Scientific and technological services, namely, management and analysis, namely, genomics management and analysis of biorepository data; scientific services, namely, medical and scientific research in the field of genetics, pharmaceuticals, oncology, and immunology and research and design relating thereto; industrial analysis and research services in the fields of medicine, genetics and pharmaceuticals; development of computer hardware and software; research relating to molecular sciences; scientific analysis in the field of molecular biology; medical research; medical laboratory services; medical and pharmacological research services; scientific research for medical purposes on biorepository data in the field of genetics, pharmaceuticals, oncology and immunology; design and development of medical technology; computer programming in the medical field analysis of human tissues for medical research; biological research, clinical research on biorepository data in the field of genetics, pharmaceuticals, oncology and immunology; medical research; design and development of medical diagnostic apparatus; scientific research for medical purposes in the area of cancerous diseases; provision of information and data relating to medical and veterinary research and development; microbiological testing in the field of diseases, disorders and conditions in the fields of oncology and immunology; biotechnology testing in the field of diseases, disorders and conditions in the fields of oncology and immunology; laboratory testing in the field of diseases, disorders and conditions in the fields of oncology and immunology; scientific research and testing services in the fields of bacteriology and virology; genetic scientific research; genetic engineering services; DNA screening for scientific research purposes; medical laboratory services, namely, laboratory analysis services relating to the treatment of persons, namely, testing and analysis of biorepository data, DNA, genetics and biological specimens

Pharmaceutical preparations for the treatment and prevention of diseases, disorders and conditions in the fields of oncology and immunology; veterinary preparations for treatment and prevention of diseases, disorders and conditions in the fields of oncology and immunology; sanitary preparations for medical purposes; diagnostic preparations for medical purposes; reagents for use in diagnostic tests for medical use; chemical diagnostic reagents for medical use; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical test reagents, namely, for use in testing and evaluating DNA, genetics, and biological specimens clinical diagnostic reagents, namely, for use in testing and evaluating DNA, genetics, and biological specimens; clinical medical reagents; contrast media for use in medical imaging; diagnostic agents for medical use; diagnostic testing materials, namely, reagents and assays for testing DNA, genetics and biological specimens for medical use; genetic identity tests comprised of reagents for medical purposes; medical diagnostic test strips for testing DNA, genetics and biological specimens; indicators, namely, strips, pellets, films and liquids for medical diagnosis, namely, chemical, biological and genetic indicators for medical diagnosis; genetic identity tests comprised of reagents for medical purposes

Apparatus for use in medical analysis of DNA, genetics and biological specimens; apparatus for carrying-out diagnostic tests for medical purposes for testing DNA, genetics and biological specimens; diagnostic apparatus for medical purposes for testing and analyzing DNA, genetics and biological specimens; medical diagnostic instruments for detecting diseases, disorders and conditions in oncology and immunology; blood testing apparatus; medical and veterinary apparatus and instruments, namely, testing apparatus for testing DNA, genetics and biological specimens; medical apparatus for taking body fluid samples; medical apparatus for tumor diagnosis; automated medical analyzers for body fluids; medical diagnostic, examination, and monitoring equipment, namely, apparatus for DNA testing for identifying, preventing and managing diseases, disorders and conditions for medical purposes in the fields of oncology and immunology; filters for blood and blood components for medical purposes; fluid collection containers for medical use; medical instruments for extracting human body fluids; electronic analyzers for medical purposes for analyzing DNA, genetics and biological specimens; automated medical analyzers for foreign matter contained in body fluids; automatic analyzers for medical diagnosis of diseases, disorders and conditions in the fields of oncology and immunology; electromedical diagnostic instruments for testing DNA, genetics and biological specimens; genetic testing apparatus for medical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 17, 2025 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 1, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Oct 1, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 1, 2025 REAP
WITHDRAWAL OF ATTORNEY GRANTED
May 29, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
May 29, 2025 WOAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 2, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 4, 2021 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 4, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 15, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 26, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Dec 11, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 7, 2018 ERRR
DATA MODIFICATION COMPLETED
Dec 3, 2018 DMCC
WITHDRAWN FROM PUB - INCOMING CORR RECEIVED
Dec 3, 2018 PBIC
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2018 CRFA
ASSIGNED TO LIE
Oct 24, 2018 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 15, 2018 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 16, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
May 16, 2018 GNSL
SUSPENSION LETTER WRITTEN
May 16, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 26, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 8, 2017 GNFN
FINAL REFUSAL E-MAILED
Nov 8, 2017 GNFR
FINAL REFUSAL WRITTEN
Nov 8, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 10, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2017 NWOS
NEW APPLICATION ENTERED
Jan 17, 2017 NWAP